AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2023

Nov 3, 2023

34576_dirs_2023-11-03_131da4e0-caeb-4bd2-bfae-b2379c363163.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-11-01

Reporting Person: Wettig Thane (CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-01	Common Stock	F	21841	$0.5471	Disposed	283921	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect

Footnotes

F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.